null

SMILES: OCc1ccccc1-c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O

InChI Key: InChIKey=VGJIQXOSXZUOKM-HSZRJFAPSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 454189   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454189 (US10717708, Example 77 | US11186544, Example 77) Show SMILES OCc1ccccc1-c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O |r| Show InChI InChI=1S/C25H24ClN3O3/c26-19-9-11-20(12-10-19)27-25(32)28-23-6-3-15-29(24(23)31)21-13-7-17(8-14-21)22-5-2-1-4-18(22)16-30/h1-2,4-5,7-14,23,30H,3,6,15-16H2,(H2,27,28,32)/t23-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.680	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454189 (US10717708, Example 77 | US11186544, Example 77) Show SMILES OCc1ccccc1-c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O |r| Show InChI InChI=1S/C25H24ClN3O3/c26-19-9-11-20(12-10-19)27-25(32)28-23-6-3-15-29(24(23)31)21-13-7-17(8-14-21)22-5-2-1-4-18(22)16-30/h1-2,4-5,7-14,23,30H,3,6,15-16H2,(H2,27,28,32)/t23-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	8.80	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454189 (US10717708, Example 77 | US11186544, Example 77) Show SMILES OCc1ccccc1-c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O |r| Show InChI InChI=1S/C25H24ClN3O3/c26-19-9-11-20(12-10-19)27-25(32)28-23-6-3-15-29(24(23)31)21-13-7-17(8-14-21)22-5-2-1-4-18(22)16-30/h1-2,4-5,7-14,23,30H,3,6,15-16H2,(H2,27,28,32)/t23-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	0.680	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454189 (US10717708, Example 77 | US11186544, Example 77) Show SMILES OCc1ccccc1-c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O |r| Show InChI InChI=1S/C25H24ClN3O3/c26-19-9-11-20(12-10-19)27-25(32)28-23-6-3-15-29(24(23)31)21-13-7-17(8-14-21)22-5-2-1-4-18(22)16-30/h1-2,4-5,7-14,23,30H,3,6,15-16H2,(H2,27,28,32)/t23-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	8.80	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair